Developer docs
API playgroundTry for free, no card

Search company profiles

Mentor Worldwide

Full company profile

uuid0007dzm

Namestring
Mentor Worldwide
Legal namestring
Mentor Worldwide LLC
Company typeenum
Private
Founded yearint
1969
Descriptiontext

Mentor Worldwide LLC is a wholly-owned subsidiary of Johnson & Johnson operating within the J&J MedTech segment. Founded in 1969 and headquartered in Irvine, California (with governing jurisdiction in New Jersey), the company manufactures and distributes FDA-cleared breast implant devices and tissue expanders for both cosmetic augmentation and reconstructive surgery. Its product portfolio centers on three breast implant lines — MemoryGel (round silicone gel), MemoryShape (anatomical/shaped silicone gel), and Saline-filled implants — plus the ARTOURA and CONTOUR PROFILE tissue expanders used primarily in post-mastectomy reconstruction. MemoryGel Enhance extends the silicone gel line specifically into the reconstruction indication. All products are Class III prescription-only medical devices manufactured in the USA, restricted to licensed healthcare providers and facilities that meet FDA labeling and patient risk/benefit disclosure requirements.

The company's business model is built on direct hardware sales through a restricted distribution network. Mentor operates the MentorDirect B2B e-commerce portal for authorized healthcare providers (physicians, hospitals, and group purchasing organizations), supplemented by an authorized distributor network and a centralized distribution warehouse in Coppell, Texas. Customers are plastic and reconstructive surgeons, hospitals, and healthcare facilities; the patient end-user (women seeking augmentation at least 18 or 22 years old, or post-mastectomy reconstruction) is served indirectly through these providers. Pricing is not publicly disclosed, and Mentor does not report standalone revenue as a J&J subsidiary. The company maintains international customer support infrastructure but its disclosed operating geography is the United States.

Mentor is positioned as a leading supplier in the North American aesthetic implants market and a key player in the global Breast Aesthetic Surgery Market, which third-party research projects to grow at an 8.5% CAGR between 2024 and 2031. The company is also advancing its FDA-cleared tissue expander portfolio into the extremity tissue expanders market, projected to reach USD 1,107.2 million by 2035, signaling a measured adjacency expansion beyond breast reconstruction. No standalone funding, M&A, leadership changes, or restructuring activity is disclosed; strategic direction appears governed entirely through the J&J MedTech parent.

Short descriptiontext

Mentor Worldwide LLC, a Johnson & Johnson MedTech subsidiary, manufactures FDA-cleared breast implants (MemoryGel, MemoryShape, saline) and tissue expanders (ARTOURA, CONTOUR PROFILE) for augmentation and post-mastectomy reconstruction, selling through a restricted B2B distribution network to licensed surgeons and healthcare facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
breast implants, tissue expanders, aesthetic medical devices, breast reconstruction devices, silicone gel implants
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Breast Implants & Tissue Expanders (Aesthetic and Reconstructive Medical Devices)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales - Breast Implants
TypeHardware Sales
Description

Sale of breast implant devices including MemoryGel, MemoryShape, and saline-filled implants to hospitals, surgeons, and authorized healthcare facilities. Products are prescription-only medical devices sold through restricted distribution channels.

mentordirect.com
2Tissue Expander Products
TypeHardware Sales
Description

Sale of tissue expanders (ARTOURA and CONTOUR PROFILE) for reconstructive surgery applications including post-mastectomy reconstruction and tissue defect procedures.

mentordirect.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1MemoryGel™
Description

Silicone gel breast implants for breast augmentation and reconstruction

mentordirect.com
+3 more records
Core offering1 text field

Mentor Worldwide LLC develops and manufactures breast implant devices and tissue expanders for breast augmentation and reconstruction procedures. The company produces silicone gel (MemoryGel, MemoryShape), saline-filled, and shaped breast implants, as well as tissue expansion devices (ARTOURA, CONTOUR PROFILE) used in post-mastectomy and reconstructive surgery. All products are prescription-only medical devices sold through restricted distribution channels to licensed healthcare providers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • North America dominated the aesthetic implants market with a 99.31% share in 2018
Product overview1 text field

Mentor Worldwide is a Johnson & Johnson MedTech company that develops and manufactures breast implant devices and tissue expanders for breast augmentation and reconstruction. The product portfolio centers on three core breast implant lines—MemoryGel™ (round silicone gel), MemoryShape™ (anatomical/shaped silicone gel), and Saline-filled implants—plus the ARTOURA™ and CONTOUR PROFILE™ tissue expanders used primarily in reconstructive procedures following mastectomy. MemoryGel Enhance extends the silicone gel line for reconstruction indications. All products are manufactured in the USA and sold through the MentorDirect distributor portal. MentorDirect also offers the MENTOR® Volume Sizing System as a sizing tool for practitioners to select appropriate implants for patients.

Product and service1 record
1MENTOR MemoryGel Breast Implants
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mentor Worldwide LLC is a subsidiary of Johnson & Johnson operating within the J&J MedTech segment. As part of the Johnson & Johnson family, Mentor benefits from corporate resources, R&D capabilities, and global distribution infrastructure while maintaining its specialized focus on breast implants and tissue expanders.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Allergan Aesthetics was the historical #1 breast implant competitor (Natrelle line) before being acquired by AbbVie. It sells silicone gel, saline, and shaped implants directly competing with Mentor's MemoryGel, MemoryShape, and saline franchises in the same plastic surgery channel.

TypeDirect peer
Description

Establishment Labs markets the Motiva breast implant line, including next-generation SmoothSilk and Ergonomix implants, and is one of Mentor's most aggressive direct competitors globally in both aesthetic and reconstructive breast surgery.

TypeDirect peer
Description

Sientra is a US-based breast implant company selling silicone gel implants and tissue expanders targeted at board-certified plastic surgeons, directly competing with Mentor in the same restricted distribution channel.

TypeDirect peer
Description

GC Aesthetics (including the Nagor and Perthese lines) is a global breast implant manufacturer with comparable silicone gel, shaped, and saline products sold to the same plastic and reconstructive surgery customer base as Mentor.

TypeDirect peer
Description

POLYTECH is a German-based manufacturer of breast implants and tissue expanders (including Microthane-coated implants) that competes head-to-head with Mentor in the European and international aesthetic and reconstructive markets.

TypeDirect peer
Description

HansBiomed is a Korean manufacturer of breast implants and tissue expanders serving the Asia-Pacific aesthetic and reconstructive market, a direct comparator for Mentor in implant technology and indications.

TypeEmerging player
Description

Ideal Implant offers a structured saline breast implant positioned as an alternative to silicone gel, providing partial overlap with Mentor's saline offering but with a single-product focus aimed at safety-conscious surgeons and patients.

TypeBroad incumbent
Description

Johnson & Johnson MedTech is Mentor's parent and a broader surgical/medical device incumbent across orthopedics, general surgery, and aesthetics; Mentor sits inside this larger portfolio and benefits from shared infrastructure and R&D.

TypeBroad incumbent
Description

AbbVie owns Allergan Aesthetics, the largest broad-line aesthetic medicine platform globally; its portfolio overlap with Mentor spans breast implants and facial aesthetics, providing a diversified competitor with deeper commercial reach.

TypeBroad incumbent
Description

Integra LifeSciences is a broader reconstructive and aesthetic surgery medical device company selling tissue expanders, implants, and regenerative products that partially overlap with Mentor's expander and implant portfolio in hospital and plastic surgery channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mentor Worldwide

Breast Implants & Tissue Expanders (Aesthetic and Reconstructive Medical Devices)mentordirect.com

Mentor Worldwide LLC, a Johnson & Johnson MedTech subsidiary, manufactures FDA-cleared breast implants (MemoryGel, MemoryShape, saline) and tissue expanders (ARTOURA, CONTOUR PROFILE) for augmentation and post-mastectomy reconstruction, selling through a restricted B2B distribution network to licensed surgeons and healthcare facilities.

What Mentor Worldwide does

Mentor Worldwide LLC is a wholly-owned subsidiary of Johnson & Johnson operating within the J&J MedTech segment. Founded in 1969 and headquartered in Irvine, California (with governing jurisdiction in New Jersey), the company manufactures and distributes FDA-cleared breast implant devices and tissue expanders for both cosmetic augmentation and reconstructive surgery. Its product portfolio centers on three breast implant lines — MemoryGel (round silicone gel), MemoryShape (anatomical/shaped silicone gel), and Saline-filled implants — plus the ARTOURA and CONTOUR PROFILE tissue expanders used primarily in post-mastectomy reconstruction. MemoryGel Enhance extends the silicone gel line specifically into the reconstruction indication. All products are Class III prescription-only medical devices manufactured in the USA, restricted to licensed healthcare providers and facilities that meet FDA labeling and patient risk/benefit disclosure requirements.

The company's business model is built on direct hardware sales through a restricted distribution network. Mentor operates the MentorDirect B2B e-commerce portal for authorized healthcare providers (physicians, hospitals, and group purchasing organizations), supplemented by an authorized distributor network and a centralized distribution warehouse in Coppell, Texas. Customers are plastic and reconstructive surgeons, hospitals, and healthcare facilities; the patient end-user (women seeking augmentation at least 18 or 22 years old, or post-mastectomy reconstruction) is served indirectly through these providers. Pricing is not publicly disclosed, and Mentor does not report standalone revenue as a J&J subsidiary. The company maintains international customer support infrastructure but its disclosed operating geography is the United States.

Mentor is positioned as a leading supplier in the North American aesthetic implants market and a key player in the global Breast Aesthetic Surgery Market, which third-party research projects to grow at an 8.5% CAGR between 2024 and 2031. The company is also advancing its FDA-cleared tissue expander portfolio into the extremity tissue expanders market, projected to reach USD 1,107.2 million by 2035, signaling a measured adjacency expansion beyond breast reconstruction. No standalone funding, M&A, leadership changes, or restructuring activity is disclosed; strategic direction appears governed entirely through the J&J MedTech parent.

Mentor Worldwide firmographics

Firmographics
Name
Mentor Worldwide
Legal name
Mentor Worldwide LLC
Website
https://mentordirect.com
Company type
Private
Founded year
1969
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Mentor Worldwide LLC, a Johnson & Johnson MedTech subsidiary, manufactures FDA-cleared breast implants (MemoryGel, MemoryShape, saline) and tissue expanders (ARTOURA, CONTOUR PROFILE) for augmentation and post-mastectomy reconstruction, selling through a restricted B2B distribution network to licensed surgeons and healthcare facilities.
Ownership category
akta.pro rank

Where Mentor Worldwide is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mentor Worldwide business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales - Breast Implants: Sale of breast implant devices including MemoryGel, MemoryShape, and saline-filled implants to hospitals, surgeons, and authorized healthcare facilities. Products are prescription-only medical devices sold through restricted distribution channels.
  2. Tissue Expander Products: Sale of tissue expanders (ARTOURA and CONTOUR PROFILE) for reconstructive surgery applications including post-mastectomy reconstruction and tissue defect procedures.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Mentor Worldwide product offering

Product offering

Core offering

Mentor Worldwide LLC develops and manufactures breast implant devices and tissue expanders for breast augmentation and reconstruction procedures. The company produces silicone gel (MemoryGel, MemoryShape), saline-filled, and shaped breast implants, as well as tissue expansion devices (ARTOURA, CONTOUR PROFILE) used in post-mastectomy and reconstructive surgery. All products are prescription-only medical devices sold through restricted distribution channels to licensed healthcare providers.

Product overview

Mentor Worldwide is a Johnson & Johnson MedTech company that develops and manufactures breast implant devices and tissue expanders for breast augmentation and reconstruction. The product portfolio centers on three core breast implant lines—MemoryGel™ (round silicone gel), MemoryShape™ (anatomical/shaped silicone gel), and Saline-filled implants—plus the ARTOURA™ and CONTOUR PROFILE™ tissue expanders used primarily in reconstructive procedures following mastectomy. MemoryGel Enhance extends the silicone gel line for reconstruction indications. All products are manufactured in the USA and sold through the MentorDirect distributor portal. MentorDirect also offers the MENTOR® Volume Sizing System as a sizing tool for practitioners to select appropriate implants for patients.

Differentiator

Problem solved

Functional benefit

Brands

  • MemoryGel™: Silicone gel breast implants for breast augmentation and reconstruction
  • MemoryShape™
  • ARTOURA™
  • CONTOUR PROFILE™

Products and services

  • MENTOR MemoryGel Breast Implants

Quantifiable outcome

  • North America dominated the aesthetic implants market with a 99.31% share in 2018

Companies that use Mentor Worldwide

Customer profile

Segments3 records

Ideal customer profiles2 records

Mentor Worldwide technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Mentor Worldwide partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Johnson & Johnson (Johnson & Johnson Services Inc.)coreStrategic or Co-development PartnerMentor Worldwide LLC is a subsidiary of Johnson & Johnson operating within the J&J MedTech segment. As part of the Johnson & Johnson family, Mentor benefits from corporate resources, R&D capabilities, and global distribution infrastructure while maintaining its specialized focus on breast implants and tissue expanders.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Mentor Worldwide competitors and assessment

Company assessment

Direct peers

  • Allergan Aesthetics (AbbVie): Allergan Aesthetics was the historical #1 breast implant competitor (Natrelle line) before being acquired by AbbVie. It sells silicone gel, saline, and shaped implants directly competing with Mentor's MemoryGel, MemoryShape, and saline franchises in the same plastic surgery channel.
  • Establishment Labs: Establishment Labs markets the Motiva breast implant line, including next-generation SmoothSilk and Ergonomix implants, and is one of Mentor's most aggressive direct competitors globally in both aesthetic and reconstructive breast surgery.
  • Sientra: Sientra is a US-based breast implant company selling silicone gel implants and tissue expanders targeted at board-certified plastic surgeons, directly competing with Mentor in the same restricted distribution channel.
  • GC Aesthetics: GC Aesthetics (including the Nagor and Perthese lines) is a global breast implant manufacturer with comparable silicone gel, shaped, and saline products sold to the same plastic and reconstructive surgery customer base as Mentor.
  • POLYTECH Health & Aesthetics: POLYTECH is a German-based manufacturer of breast implants and tissue expanders (including Microthane-coated implants) that competes head-to-head with Mentor in the European and international aesthetic and reconstructive markets.
  • HansBiomed: HansBiomed is a Korean manufacturer of breast implants and tissue expanders serving the Asia-Pacific aesthetic and reconstructive market, a direct comparator for Mentor in implant technology and indications.

Emerging players

  • Ideal Implant: Ideal Implant offers a structured saline breast implant positioned as an alternative to silicone gel, providing partial overlap with Mentor's saline offering but with a single-product focus aimed at safety-conscious surgeons and patients.

Broad incumbents

  • Johnson & Johnson MedTech: Johnson & Johnson MedTech is Mentor's parent and a broader surgical/medical device incumbent across orthopedics, general surgery, and aesthetics; Mentor sits inside this larger portfolio and benefits from shared infrastructure and R&D.
  • AbbVie: AbbVie owns Allergan Aesthetics, the largest broad-line aesthetic medicine platform globally; its portfolio overlap with Mentor spans breast implants and facial aesthetics, providing a diversified competitor with deeper commercial reach.
  • Integra LifeSciences: Integra LifeSciences is a broader reconstructive and aesthetic surgery medical device company selling tissue expanders, implants, and regenerative products that partially overlap with Mentor's expander and implant portfolio in hospital and plastic surgery channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Mentor Worldwide social profiles

Digital presence

Mentor Worldwide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mentor Worldwide leadership team

Management profile

Number of profiles

Mentor Worldwide funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mentor Worldwide M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mentor Worldwide

What does Mentor Worldwide do?

Mentor Worldwide LLC develops and manufactures breast implant devices and tissue expanders for breast augmentation and reconstruction procedures. The company produces silicone gel (MemoryGel, MemoryShape), saline-filled, and shaped breast implants, as well as tissue expansion devices (ARTOURA, CONTOUR PROFILE) used in post-mastectomy and reconstructive surgery. All products are prescription-only medical devices sold through restricted distribution channels to licensed healthcare providers.

Is Mentor Worldwide a public or private company?

Mentor Worldwide is a private company. It is classified as corporate owned and is currently operating.

When was Mentor Worldwide founded?

Mentor Worldwide was founded in 1969. It employs 1,001 to 5,000 people.

Where is Mentor Worldwide based?

Mentor Worldwide is headquartered in Irvine, United States, in the North America region.

How does Mentor Worldwide make money?

Two revenue lines are on record. Medical Device Sales - Breast Implants are the primary driver. The others are tissue Expander Products.

Who are Mentor Worldwide's main competitors?

Direct peers on record are Allergan Aesthetics (AbbVie), Establishment Labs, Sientra, GC Aesthetics, POLYTECH Health & Aesthetics and HansBiomed. Ideal Implant is listed as an emerging player. Broad incumbents are Johnson & Johnson MedTech, AbbVie and Integra LifeSciences.

Does Mentor Worldwide have an API?

No public API is recorded for Mentor Worldwide.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioWorldBellaseno speeds breast scaffold trial as J&J deal clears path to marketBellaseno GmbH is accelerating its absorbable breast scaffold development, with a pivotal Australian trial recruiting faster than expected. A licensing deal with Johnson & Johnson subsidiary Mentor Worldwide positions the technology for global commercialization.openPR.comExtremity Tissue Expanders Market to Reach USD$ 655.4 million in 2026 and projected to hit USD$ 1,107.2 million by 2035., United States Growth in Plastic Surgery, Reconstructive Surgery, Advanced TissDataM Intelligence published a market research report projecting the global extremity tissue expanders market to grow from USD 618.3 million in 2025 to USD 1,107.2 million by 2035, representing a compound annual growth rate of 6.1% during the forecast period. Key industry developments include AbbVie Inc. completing strategic portfolio expansion of its Allergan division, Mentor Worldwide LLC advancing its FDA-cleared expander strategy, and RTI Surgical executing an acquisition of Collagen Solutions to enhance biologic scaffold capabilities. North America continues to lead the market due to advanced healthcare infrastructure and high reconstructive surgery volumes.openPR.comBreast Aesthetic Surgery Market (2026) | Silicone Implants, Fat Grafting, Body Contouring & Growth Drivers | Top Companies 2026 - Alma Lasers, Mentor Worldwide LLC, GC Aesthetics plc, Aesthetics GmbHDataM Intelligence released a market research report on the Breast Aesthetic Surgery Market, projecting growth at a CAGR of 8.5% between 2024 and 2031, driven by technological advancements in breast implant technologies, rising consumer acceptance of cosmetic procedures, and expanding adoption of minimally invasive techniques. Key industry developments include Allergan expanding its breast implant portfolio with enhanced safety features, Mentor Worldwide introducing next-generation implants, and several strategic mergers and acquisitions by GC Aesthetics, Establishment Labs, and Allergan Aesthetics to strengthen market positioning. The report identifies North America as the leading regional market, with Asia-Pacific showing rapid growth due to rising medical tourism and disposable incomes.PR NewswireGlobal Breast Implant Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and ForecastsResearchAndMarkets.com published a global breast implant market report covering 2021-2027, finding the market reached US$ 2.48 billion in 2021 and is projected to grow to US$ 3.35 billion by 2027 at a CAGR of 4.60%. The report attributes growth to increasing demand for cosmetic surgeries, rising breast cancer prevalence, and technological advancements in implant materials. It also profiles key industry players including Allergan plc, Establishment Labs SA, Mentor Worldwide LLC (Johnson & Johnson), and Sientra Inc.PR NewswireU.S. FDA Approves New MENTOR® MemoryGel BOOST™ Breast ImplantMentor Worldwide LLC, part of Johnson & Johnson Medical Devices Companies, announced that the U.S. FDA approved its MENTOR® MemoryGel BOOST™ Breast Implant for breast augmentation in women at least 22 years old and for breast reconstruction in women of all ages, with commercial availability in early 2022. The new implant addresses surgeon demand for an option combining increased form stability to shape the breast with a soft, natural feel, filling an unmet need in the breast aesthetics market. Clinical survey data showed patients and surgeons preferred the MemoryGel BOOST™ implant as feeling more like a natural breast compared to a leading competitor product.PR NewswireThe Global Tissue Expander Market is expected to grow from USD 1,223.13 Million in 2018 to USD 1,857.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.14%A market research report forecasts that the global tissue expander market will grow from USD 1,223.13 million in 2018 to USD 1,857.12 million by 2025 at a CAGR of 6.14%. The analysis evaluates leading vendors including Allergan plc, Mentor Worldwide LLC, and Sientra, Inc. based on business strategy and product satisfaction using proprietary positioning matrices.PR NewswireUS Breast Implant Market Size, Trends & Forecast 2025The US breast implant market was valued at approximately $800 million in 2018 and is projected to grow at a compound annual growth rate exceeding 10% through 2025, reaching over $1 billion, with the US accounting for more than 30% of the global market. Over 300,000 breast augmentation procedures were performed in the US in 2018, with women aged 19-34 representing the largest demographic segment at 48.5%, and silicone implants remaining the preferred choice. The market growth is attributed to the presence of major manufacturers Mentor Worldwide and Allergan, increasing acceptance of cosmetic procedures, rising breast cancer incidence, and technological advancements improving implant quality.PR NewswireFDA issues warning letters to two breast implant manufacturers for failure to comply with post-approval study requirementsThe U.S. Food and Drug Administration issued warning letters to Mentor Worldwide LLC and Sientra, Inc. for failing to comply with post-approval study requirements for breast implants. Both companies were found to have serious deficiencies in their studies, including low patient enrollment and follow-up rates. The FDA expects the manufacturers to correct these violations within 15 working days to ensure long-term patient safety.PR NewswireGlobal $684 Million Breast Reconstruction Market to 2025A market research report projects the global breast reconstruction market will grow from US$526.5 million in 2017 to US$684.5 million by 2025, at a compound annual growth rate of 3.5%. The report identifies rising breast cancer prevalence and increasing cosmetic procedures as key growth drivers, while post-surgical complications and high procedure costs act as market restraints. Key players identified in the market include Allergan Plc, Mentor Worldwide LLC, Sientra Inc., and other companies operating in the breast implants and reconstructive surgery sector.PR NewswireBreast Implants Caused Form of Lymphoma in Ohio Woman, First-Of-Its-Kind Lawsuit AllegesAn Ohio woman filed a lawsuit in New Jersey Superior Court alleging that breast implants manufactured by Mentor Worldwide, a Johnson & Johnson subsidiary, caused her to develop anaplastic large cell lymphoma (BIA-ALCL), marking what is believed to be the first such national lawsuit against J&J and its subsidiaries. The FDA has received over 410 reports related to BIA-ALCL, including 9 deaths, with textured implants showing higher correlation than smooth implants. The lawsuit alleges that Mentor recklessly failed to warn consumers of cancer risks and did not comply with FDA-mandated product safety studies, as the plaintiff seeks accountability for herself and potentially other affected women.